Shandong Wit Dyne Health Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Z28
CNY
31.76
-0.88 (-2.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
432.12
554.19
616.29
743.91
223.57
582.61
571.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
432.12
554.19
616.29
743.91
223.57
582.61
571.80
Raw Material Cost
82.89
91.28
93.57
135.88
68.21
85.11
95.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
174.24
94.13
108.10
188.31
77.73
106.31
105.21
Other Expenses
2.56
2.55
1.14
3.32
1.67
2.86
1.00
Total Expenditure (Excl Depreciation)
282.77
210.95
213.02
357.41
162.62
219.99
210.62
Operating Profit (PBDIT) excl Other Income
149.3
343.2
403.29999999999995
386.5
61
362.59999999999997
361.2
Other Income
5.74
13.91
8.56
8.76
18.65
15.86
16.56
Operating Profit (PBDIT)
145.46
359.64
419.77
371.70
93.14
388.87
386.28
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
3.14
0.68
4.34
3.95
1.40
0.28
4.41
Gross Profit (PBDT)
349.23
462.91
522.72
608.03
155.36
497.51
476.40
Depreciation
0.00
17.33
17.33
20.93
20.93
17.66
17.66
Profit Before Tax
148.60
342.99
406.78
354.72
73.61
371.48
373.03
Tax
20.95
49.03
61.56
42.44
12.15
60.01
57.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
70.60
155.12
182.35
150.17
33.55
163.24
168.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
70.60
155.12
182.35
150.17
33.55
163.24
168.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
57.64
138.22
163.50
163.27
28.22
148.98
149.97
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
128.24
293.34
345.85
313.44
61.77
312.21
318.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,851.05
2,780.46
3,094.00
2,911.65
2,761.48
2,845.09
3,150.52
Earnings per share (EPS)
0.3
0.66
0.78
0.64
0.14
0.7
0.72
Diluted Earnings per share
0.3
0.66
0.78
0.64
0.14
0.7
0.72
Operating Profit Margin (Excl OI)
32.33%
59.26%
63.91%
45.98%
23.96%
60.99%
61.57%
Gross Profit Margin
34.39%
65.02%
68.82%
50.5%
42.28%
66.79%
68.33%
PAT Margin
16.34%
27.99%
29.59%
20.19%
15.01%
28.02%
29.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -22.03% vs -10.08% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -56.29% vs -15.18% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -59.59% vs -15.93% in Jun 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Shandong Wit Dyne Health Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
432.12
0
432.12
Other Operating Income
0.00
0.00
0.00
Total Operating income
432.12
0
432.12
Raw Material Cost
82.89
0
82.89
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
174.24
0
174.24
Other Expenses
2.56
0.00
2.56
Total Expenditure (Excl Depreciation)
282.77
0
282.77
Operating Profit (PBDIT) excl Other Income
149.35
0.00
149.35
Other Income
5.74
0
5.74
Operating Profit (PBDIT)
145.46
0
145.46
Interest
0.00
0
0.00
Exceptional Items
3.14
0
3.14
Gross Profit (PBDT)
349.23
0
349.23
Depreciation
0.00
0
0.00
Profit Before Tax
148.60
0
148.60
Tax
20.95
0
20.95
Provisions and contingencies
0
0
0.00
Profit After Tax
70.60
0
70.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
70.60
0
70.60
Share in Profit of Associates
0
0
0.00
Minority Interest
57.64
0
57.64
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.24
0
128.24
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,851.05
0
2,851.05
Earnings per share (EPS)
0.30
0
0.30
Diluted Earnings per share
0.30
0
0.30
Operating Profit Margin (Excl OI)
32.33%
0%
0.00
32.33%
Gross Profit Margin
34.39%
0%
0.00
34.39%
PAT Margin
16.34%
0%
0.00
16.34%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 43.21 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -22.03% vs -10.08% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 93.25% vs -60.46% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.82 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -56.29% vs -15.18% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 107.44% vs -77.03% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.97 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -59.59% vs -15.93% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 87.52% vs -77.06% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.33%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024